# US 2023/0398158 A1 · New composition for treatment of skin conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0398158 A1
- Document ID: US20230398158A1
- Status: Published application
- Kind: A1
- Application number: 18/251,657
- Filed: 2021-11-04
- Published: 2023-12-14
- Earliest claimed: 2020-11-05
- Assignees: Lactobio A/S
- Applicants: Lactobio A/S
- Inventors: Charlotte VEDEL; Katja Billekop OLSEN; Søren KJÆRULFF; Sigurd CHRISTENSEN
- Web page: https://patentgrep.com/patent/US20230398158A1

## CPC

- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- C12N 1/20: Bacteria; Culture media therefor
- A61K 8/362: Polycarboxylic acids
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 8/99: from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/191: having two or more hydroxy groups, e.g. gluconic acid
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/60: Salicylic acid; Derivatives thereof
- A61K 38/164: {from bacteria}
- A61P 17/10: Anti-acne agents
- A61P 31/02: Local antiseptics
- A61Q 17/005: {Antimicrobial preparations}
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/08: Anti-ageing preparations
- C12R 2001/225: Lactobacillus
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention relates to a composition for improvement of a skin condition comprising a supernatant produced from fermentation of a bacteria wherein the supernatant comprises at least 3 metabolites produced by the bacteria during fermentation wherein the at least 3 metabolites include at least one of succinic acid, 2-Hydroxyisocaproic acid, azelaic acid and/or salicylic acid, 5 and wherein at least one of succinic acid, 2-Hydroxyisocaproic acid, azelaic acid, and/or salicylic acid is/are produced by fermentation of a lactic acid bacteria.

## Claims

### Claim at position 1

-15. (canceled)

### Claim 16

Composition for improvement of a skin condition comprising a supernatant produced from fermentation of a bacteria wherein the supernatant comprises at least 3 metabolites produced by the bacteria during fermentation wherein the at least 3 metabolites include at least one of succinic acid, 2-Hydroxyisocaproic acid, azelaic acid and/or salicylic acid, and wherein at least one of succinic acid, 2-Hydroxyisocaproic acid, azelaic acid, and/or salicylic acid is/are produced by fermentation of a lactic acid bacteria.

### Claim 17 (depends on 16)

Composition of claim 16 wherein the at least 3 metabolites are selected from; bacteriocins, lactic acid, acetic acid, succinic acid, azelaic acid, salicylic acid, indole-3-lactic acid, indole-3-acetic acid, 2-Hydroxyisocaproic acid, 2-hydroxybuturic acid, N-acetyl tryptophan, glycolic acid, N-acetyl glutamin and N-acetylaspartic acid.

### Claim 18

Composition for improvement of a skin condition comprising a supernatant produced from fermentation of a bacteriocin producing bacteria wherein same bacteria produces at least two of the following metabolites; lactic acid, acetic acid, succinic acid, azelaic acid, salicylic acid, indole-3-lactic acid, 2-Hydroxyisocaproic acid, indole-3-acetic acid, 2-hydroxybuturic acid, N-acetyl tryptophan, glycolic acid, N-acetyl glutamin and N-acetylaspartic acid.

### Claim 19

Composition for improvement of a skin condition comprising salicylic acid wherein the salicylic acid is produced by fermentation of a lactic acid bacteria.

### Claim 20

Composition for improvement of a skin condition comprising succinic acid wherein the succinic acid is produced by fermentation of a lactic acid bacteria.

### Claim 21

Composition for improvement of a skin condition comprising 2-Hydroxyisocaproic acid wherein the 2-Hydroxyisocaproic acid is produced by fermentation of a lactic acid bacteria.

### Claim 22

Composition for improvement of a skin condition comprising azelaic acid and salicylic acid, and wherein the azelaic acid and the salicylic acid are produced by fermentation of a lactic acid bacteria.

### Claim 23

Composition according to any of the proceeding claims further comprising at least one antimicrobial bacterial metabolite chosen from a group comprising hydrogen peroxide, phenyllactic acid, 3-hydroxyphenyllactic acid, 4-hydroxyphenylactic acid, 3-hydroxy propanaldehyde, 1,2 propandiol, 1,3 propandiol, succinic acid, ethanol, acetic acid, carbonic acid, propanoic acid, butyric acid, cyclic dipeptides, cyclo(L-Phe-L-Pro), cyclo(L P-Traps-4-OH-L-Pro), 3-(R)-hydroxydecanoic acid, 3-hydroxy-5-cic dodecanoic acid, 3-(R)-hydroxy dodecanoic acid, 2-Hydroxyisocaproic acid and 3-(R)-hyroxytetradecanoic acid.

### Claim 24

Composition according to any of the proceeding claims, wherein the bacteriocin producing bacteria is selected from a group comprising Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus casei, Lactobacillus johnsonii, Lactobacillus rahamnosus, Lactobacillus gasseri, Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium longum, Saccharomyces boulardii, Lactobacillus salivarus, Bacteroides spp, Enterococcus faecium, Lactobacillus delbrucekii spp bulgaricus, Lactobacillus cellibiosus, Lactobacillus curvatus, Lactobacillus brevis, Bifidobacterium bifidum, Bifidobacterium adolescsents, Bifidobacterium animalis, Bifidobacterium thermophilium, Enterococcus faecalis, Streptococcus cremoris, Streptococcus salivarius, Streptococcus diacetylactis, Streptococcus intermedius, Lactobacillus paracasei, Streptococcus thermophiles, Streptococcus salivarius subsp. Thermophilus, Bacillus cereus, Proprionibacteria freundenreichii, Bacillus coagulans (L. sporegenes), Oxalobacter formagenes, Bifidobacterium bifidus, and Leuconostoc mesenteroides.

### Claim 25 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24)

Topical formulation comprising the composition according to any of claims 16-24, wherein the topical formulation is a cosmetical product or a pharmaceutical product.

### Claim 26 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24)

A pharmaceutical product comprising the composition according to anyone of claims 16-24 for the treatment or prevention of a skin condition.

### Claim 27 (depends on 26)

The pharmaceutical product according to claim 26, wherein the skin condition is an inflammatory or infectious disease or skin damage or a dysfunctional skin microbiome.

### Claim 28 (depends on 26)

The pharmaceutical product according to claim 26, wherein the skin condition is selected from: acne, rosacea, eczema, atopic dermatitis and psoriasis.

### Claim 29 (depends on 26)

The pharmaceutical product according to claim 26, wherein the skin condition is selected from: photodamage, aging, striae and scars.

### Claim 30 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24)

Process to produce a composition according to anyone of claims 16 to 24 wherein the process involves fermentation of an isolated lactic acid bacteria.
